EMILY GEORGE: Open Payments
NPI 1992584221 · BRIGHAM CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 29 payments from 10 companies in 2025. Trend: 2023 $52 · 2024 $437 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $193 |
| ABBVIE INC. | 4 | $75 |
| Dexcom, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Astellas Pharma US Inc | 1 | $31 |
| PFIZER INC. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Organon LLC | 1 | $12 |
Products named: OTEZLA, EVENITY, VRAYLAR, Dexcom G6 Transmitter, CAPLYTA, TAVNEOS, Veozah, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
